ATE407121T1 - Gegen säurebeständige bakterien wirksame antibakterielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten - Google Patents
Gegen säurebeständige bakterien wirksame antibakterielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthaltenInfo
- Publication number
- ATE407121T1 ATE407121T1 AT01904335T AT01904335T ATE407121T1 AT E407121 T1 ATE407121 T1 AT E407121T1 AT 01904335 T AT01904335 T AT 01904335T AT 01904335 T AT01904335 T AT 01904335T AT E407121 T1 ATE407121 T1 AT E407121T1
- Authority
- AT
- Austria
- Prior art keywords
- active ingredient
- carboxylic acids
- antibacterial agents
- effective against
- resistant bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title 1
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 abstract 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000038099 | 2000-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE407121T1 true ATE407121T1 (de) | 2008-09-15 |
Family
ID=18561886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01904335T ATE407121T1 (de) | 2000-02-09 | 2001-02-07 | Gegen säurebeständige bakterien wirksame antibakterielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7176313B2 (de) |
| EP (1) | EP1262477B1 (de) |
| KR (1) | KR100817425B1 (de) |
| CN (1) | CN1312131C (de) |
| AT (1) | ATE407121T1 (de) |
| AU (2) | AU2001232238B2 (de) |
| CA (1) | CA2398988C (de) |
| DE (1) | DE60135640D1 (de) |
| DK (1) | DK1262477T3 (de) |
| ES (1) | ES2312411T3 (de) |
| HK (1) | HK1048118B (de) |
| IL (2) | IL151035A0 (de) |
| MX (1) | MXPA02007667A (de) |
| NO (1) | NO325656B1 (de) |
| PT (1) | PT1262477E (de) |
| RU (2) | RU2297420C2 (de) |
| TW (1) | TWI283668B (de) |
| WO (1) | WO2001058876A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2003076428A1 (ja) * | 2002-03-08 | 2005-07-07 | 第一製薬株式会社 | キノロンカルボン酸誘導体 |
| US7459005B2 (en) | 2002-11-22 | 2008-12-02 | Akzo Nobel N.V. | Chemical composition and method |
| DE10314634A1 (de) * | 2003-04-01 | 2004-10-14 | Khs Maschinen- Und Anlagenbau Ag, Patentabteilung | Spülbares Huborgan |
| SG144936A1 (en) | 2003-09-10 | 2008-08-28 | Kyorin Seiyaku Kk | 7-(4-substituted-3-cyclopropylaminomethyl-1- pyrrolidinyl)quinolonecarboxylic acid derivative |
| JP4619952B2 (ja) * | 2003-09-29 | 2011-01-26 | 第一三共株式会社 | ８−シアノキノロンカルボン酸誘導体 |
| ITMI20032259A1 (it) * | 2003-11-20 | 2005-05-21 | Chemi Spa | Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione |
| TW200640899A (en) * | 2005-01-21 | 2006-12-01 | Daiichi Seiyaku Co | Fluoroalkylpyrrolidine derivative |
| US8129533B2 (en) | 2005-09-28 | 2012-03-06 | Dalichi Sankyo Company, Limited | Method for production of quinolone-containing lyophilized preparation |
| JP5174365B2 (ja) * | 2007-03-23 | 2013-04-03 | 第一三共株式会社 | キノロン含有凍結乾燥製剤の製造方法 |
| RU2318513C1 (ru) * | 2007-04-10 | 2008-03-10 | Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") | Лекарственное средство на основе d-циклосерина, препарат пролонгированного действия, содержащий наночастицы, способ его получения |
| CA2688008A1 (en) * | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| EP2310388B1 (de) * | 2008-06-17 | 2015-08-05 | Institut Pasteur Korea | Pyridopyrimidinverbindungen als mittel gegen tuberkulose |
| CA2762022A1 (en) | 2009-05-15 | 2010-11-18 | Redx Pharma Limited | Redox drug derivatives |
| AU2011206761A1 (en) * | 2010-01-13 | 2012-07-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anti - infective pyrido (1,2 -a) pyrimidines |
| CA2904387C (en) | 2013-03-15 | 2021-12-07 | Melinta Therapeutics, Inc. | Methods of treating infections in overweight and obese patients using antibiotics |
| CN103381169A (zh) * | 2013-07-04 | 2013-11-06 | 丁圣雨 | Chukrasone A在抗结核菌药物中的应用 |
| KR20230085439A (ko) | 2021-12-07 | 2023-06-14 | 대한민국(국립마산병원장) | 비결핵 항산균 감염 질환의 예방 또는 치료용 조성물 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5872589A (ja) * | 1981-10-28 | 1983-04-30 | Dai Ichi Seiyaku Co Ltd | ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体 |
| JPS6212760A (ja) | 1984-12-14 | 1987-01-21 | Dai Ichi Seiyaku Co Ltd | １−（２−ハロゲノシクロプロピル）キノリンカルボン酸誘導体 |
| JPS61205258A (ja) | 1985-03-08 | 1986-09-11 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体及びその製造方法 |
| US4977154A (en) | 1985-12-12 | 1990-12-11 | Warner-Lambert Company | 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents |
| JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
| US4777253A (en) * | 1986-04-25 | 1988-10-11 | Abbott Laboratories | Process for preparation of racemate and optically active ofloxacin and related derivatives |
| NO885426L (no) | 1987-12-11 | 1989-06-12 | Dainippon Pharmaceutical Co | Kinolinderivater, samt fremgangsmaate ved fremstilling derav. |
| MY105136A (en) * | 1988-04-27 | 1994-08-30 | Daiichi Seiyaku Co | Optically active pyridonecarboxylic acid derivatives. |
| DE68907996T2 (de) | 1988-05-11 | 1994-01-05 | Abbott Lab | Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests. |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| FI95130C (fi) | 1988-07-20 | 1995-12-27 | Sankyo Co | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi |
| JP3026162B2 (ja) | 1988-08-31 | 2000-03-27 | 第一製薬株式会社 | スピロ化合物 |
| CA1336090C (en) * | 1988-08-31 | 1995-06-27 | Isao Hayakawa | Spiro-substituted cyclic amines of quinolone derivatives |
| JPH0324013A (ja) * | 1989-06-21 | 1991-02-01 | Kyowa Hakko Kogyo Co Ltd | 抗腫瘍剤 |
| JPH0381224A (ja) * | 1989-08-22 | 1991-04-05 | Otsuka Pharmaceut Co Ltd | ライ病治療剤 |
| DE4120646A1 (de) * | 1991-06-22 | 1992-12-24 | Bayer Ag | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
| US6075024A (en) * | 1991-11-27 | 2000-06-13 | Sepracor Inc. | Methods for treating infection using optically pure (S)-lomefloxacin |
| NO304832B1 (no) * | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
| JPH0649059A (ja) * | 1992-07-23 | 1994-02-22 | Hokuriku Seiyaku Co Ltd | ７−（５−アザスピロ〔２，４〕ヘプタン−５−イル）−８−アルコキシキノリン−３−カルボン酸誘導体 |
| JP3268098B2 (ja) | 1992-12-25 | 2002-03-25 | 第一製薬株式会社 | 二環性環状アミン誘導体 |
| JPH06271568A (ja) * | 1993-03-22 | 1994-09-27 | Hokuriku Seiyaku Co Ltd | ７−フェニルピペラジニルキノリン−３−カルボン酸誘導体 |
| TW252107B (de) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| WO2001062734A1 (en) | 2000-02-25 | 2001-08-30 | Daiichi Pharmaceutical Co., Ltd. | Process for producing quinolonecarboxylic acids and intermediates thereof |
| AU2001244671B2 (en) | 2000-03-31 | 2005-01-27 | Daiichi Pharmaceutical Co., Ltd. | Quinolonecarboxylic acid derivative |
-
2001
- 2001-02-07 AT AT01904335T patent/ATE407121T1/de active
- 2001-02-07 HK HK03100293.1A patent/HK1048118B/en not_active IP Right Cessation
- 2001-02-07 KR KR1020027010292A patent/KR100817425B1/ko not_active Expired - Fee Related
- 2001-02-07 PT PT01904335T patent/PT1262477E/pt unknown
- 2001-02-07 ES ES01904335T patent/ES2312411T3/es not_active Expired - Lifetime
- 2001-02-07 EP EP01904335A patent/EP1262477B1/de not_active Expired - Lifetime
- 2001-02-07 MX MXPA02007667A patent/MXPA02007667A/es active IP Right Grant
- 2001-02-07 WO PCT/JP2001/000861 patent/WO2001058876A1/ja not_active Ceased
- 2001-02-07 RU RU2004137055/04A patent/RU2297420C2/ru not_active IP Right Cessation
- 2001-02-07 AU AU2001232238A patent/AU2001232238B2/en not_active Ceased
- 2001-02-07 DK DK01904335T patent/DK1262477T3/da active
- 2001-02-07 CA CA2398988A patent/CA2398988C/en not_active Expired - Fee Related
- 2001-02-07 DE DE60135640T patent/DE60135640D1/de not_active Expired - Lifetime
- 2001-02-07 US US10/203,199 patent/US7176313B2/en not_active Expired - Fee Related
- 2001-02-07 IL IL15103501A patent/IL151035A0/xx unknown
- 2001-02-07 AU AU3223801A patent/AU3223801A/xx active Pending
- 2001-02-07 CN CNB018077331A patent/CN1312131C/zh not_active Expired - Fee Related
- 2001-02-07 RU RU2002121245/04A patent/RU2299205C2/ru not_active IP Right Cessation
- 2001-02-09 TW TW090102897A patent/TWI283668B/zh not_active IP Right Cessation
-
2002
- 2002-08-01 IL IL151035A patent/IL151035A/en not_active IP Right Cessation
- 2002-08-08 NO NO20023764A patent/NO325656B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002121245A (ru) | 2004-04-10 |
| CN1312131C (zh) | 2007-04-25 |
| CA2398988C (en) | 2010-06-22 |
| US20030119848A1 (en) | 2003-06-26 |
| NO325656B1 (no) | 2008-06-30 |
| CN1422256A (zh) | 2003-06-04 |
| IL151035A0 (en) | 2003-04-10 |
| KR20020074517A (ko) | 2002-09-30 |
| DE60135640D1 (de) | 2008-10-16 |
| PT1262477E (pt) | 2008-11-14 |
| RU2297420C2 (ru) | 2007-04-20 |
| IL151035A (en) | 2008-12-29 |
| NO20023764L (no) | 2002-10-09 |
| DK1262477T3 (da) | 2008-12-01 |
| US7176313B2 (en) | 2007-02-13 |
| AU3223801A (en) | 2001-08-20 |
| EP1262477A4 (de) | 2003-07-02 |
| WO2001058876A1 (en) | 2001-08-16 |
| HK1048118B (en) | 2009-01-09 |
| KR100817425B1 (ko) | 2008-03-27 |
| ES2312411T3 (es) | 2009-03-01 |
| AU2001232238B2 (en) | 2005-03-24 |
| MXPA02007667A (es) | 2003-04-14 |
| NO20023764D0 (no) | 2002-08-08 |
| CA2398988A1 (en) | 2001-08-16 |
| RU2004137055A (ru) | 2006-05-27 |
| RU2299205C2 (ru) | 2007-05-20 |
| EP1262477A1 (de) | 2002-12-04 |
| EP1262477B1 (de) | 2008-09-03 |
| HK1048118A1 (en) | 2003-03-21 |
| TWI283668B (en) | 2007-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60135640D1 (de) | Rielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten | |
| BR9916798A (pt) | 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek | |
| ATE346046T1 (de) | Chinoline und deren in der 4-stellung durch eine piperazinhaltige gruppe substituierte nitrogenierte derivate und deren verwendung als antibakterielle mittel | |
| ATE266662T1 (de) | Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten | |
| EP0900795A4 (de) | Heterocyclisch substituierte benzolderivate und herbizide | |
| EP0513387A4 (en) | Active oxygen inhibitor | |
| BG106158A (en) | New use of compounds as antibacterial agents | |
| NO900639D0 (no) | Selektivt antibakterielt middel. | |
| EP1426365A4 (de) | 3-phenoxy-4-pyridazinolderivat und dieses enthaltende herbizide zusammensetzung | |
| ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
| ATE128707T1 (de) | Quinoloncarbonsäurederivat. | |
| ATE504573T1 (de) | Pyrazolderivate, deren zwischenprodukte, verfahren zu deren herstellung und herbizid, das diese verbindungen als wirkstoff enthält | |
| FI942290A0 (fi) | Uudet herbisidit | |
| DK0712853T3 (da) | Pyrazolderivat | |
| AU2001232238A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
| EP0757987A4 (de) | Pyrazolcarbonsäurederivat und ein mittel zur bekämpfung von pflanzenkrankheiten | |
| DE69818261D1 (en) | Hydroxycyclopentanone | |
| DE69825977D1 (de) | Antivirale mittel | |
| EP0791572A4 (de) | Substituierte bicycloheptandione und herbizide | |
| NO20013544D0 (no) | Middel for å behandle Parkinsons sykdom samt anvendelse derav | |
| DK1349457T3 (da) | Væskeformige antimikrobemidler | |
| NO20070421L (no) | Radiosensitiviserende middel | |
| DE69836331D1 (de) | 2-sulfamoylbenzoesäure-derivate | |
| WO2004094370A3 (en) | Antibacterial pyrazole carboxylic acid hydrazides | |
| EP0601197A4 (de) | Derivate der 5-aminochinoloncarbonsäure und sie als aktivbestandteil enthaltende antibakterielle mittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1262477 Country of ref document: EP |